LABCORP HOLDINGS INC. 10-K

Item 2. PROPERTIES The Company's corporate headquarters are located in Burlington, North Carolina, and include facilities that are both owned and leased. Labcorp Diagnostics (Dx) operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The table below summarizes certain information as to Dx's principal operating and administrative facilities as of December 31, 2020. Location Nature of Occupancy Primary Facilities: Birmingham, Alabama Leased Phoenix, Arizona Owned Los Angeles, California Leased Monrovia, California Leased San Diego, California Leased San Francisco, California Leased Shelton, Connecticut Leased Tampa, Florida Leased Westborough, Massachusetts Leased St. Paul, Minnesota Owned Raritan, New Jersey Owned Burlington, North Carolina (5) Owned/Leased Research Triangle Park, North Carolina (3) Leased Dublin, Ohio Owned Brentwood, Tennessee Leased Dallas, Texas Leased Houston, Texas Leased Herndon, Virginia Leased Seattle, Washington Leased Spokane, Washington (3) Leased 46 Index Labcorp Drug Development (DD) operates on a global scale. The table below summarizes certain information as to DD's principal operating and administrative facilities as of December 31, 2020. Location Nature of Occupancy Primary Facilities: Mechelen, Belgium Leased Beijing, China Leased Shanghai, China (2) Owned/Leased Muenster, Germany Owned Pune, India Leased Bangalore, India Leased Singapore Leased Geneva, Switzerland Owned Eye, United Kingdom Owned Harrogate, United Kingdom Owned Huntingdon, United Kingdom Owned Leeds, United Kingdom Owned Maidenhead, United Kingdom Leased Shardlow, United Kingdom Owned York, United Kingdom Leased San Francisco, California Leased Daytona Beach, Florida Leased Greenfield, Indiana Owned Indianapolis, Indiana Leased Gaithersburg, Maryland Leased Ann Arbor, Michigan Leased Minneapolis, Minnesota Leased Princeton, New Jersey Leased Somerset, New Jersey Owned Dallas, Texas Leased Chantilly, Virginia Leased Madison, Wisconsin Owned All of the Company’s primary laboratory and drug development facilities have been built or improved for the purpose of providing commercial laboratory testing or drug development services. The Company believes that these existing facilities and plans for expansion are suitable and adequate and will provide sufficient production capacity for the Company's currently foreseeable level of operations. The Company believes that if it were unable to renew a lease or if a lease were to be terminated on any of the facilities it presently leases, it could find alternate space at competitive market rates and readily relocate its operations to such new locations without material disruption to its operations. Item 3. LEGAL PROCEEDINGS See Note 16 Commitments and Contingencies to the Consolidated Financial Statements. Item 4. MINE SAFETY DISCLOSURES Not applicable. 47 Index PART II